Children with heart devices and their parents struggle with quality of life
December 04, 2012
- Children with implanted heart devices and their parents may report a lower quality of life than other kids and their parents.
- For children, self-perception, self-worth and athletic capability lowered quality of life.
- For parents, their child’s behavior was the biggest factor related to quality of life.
EMBARGOED UNTIL 4 pm ET, Tuesday, December 4, 2012
DALLAS, Dec. 4, 2012 – Children with implanted heart-rhythm devices
and their parents suffer from a lower quality of life compared with their healthy counterparts and may benefit from psychotherapy according to new research in Circulation: Arrhythmia & Electrophysiology
American Heart Association journal.
The children, ages 8 to 18 years old, and their parents completed quality of life questionnaires.
Compared with healthy children and their parents, children with heart devices and their parents reported significantly lower quality of life scores. Likewise, their scores were also lower than those of children with mild congenital heart disease. However, their quality of life scores were similar to those for children with more severe heart disease but no device.
For children, self-perception, self-worth, and athletic capability affected quality of life.
For parents, their child’s behavior was the biggest factor related to quality of life.
Also, children with an implantable defibrillator tended to have lower quality of life scores than those with pacemakers.
“These findings should encourage us to consider the negative impact of devices, particularly defibrillators, on pediatric patients; and to develop strategies to mitigate these effects,” said Richard J. Czosek, M.D., study author and assistant professor of pediatrics at the Cincinnati Children’s Hospital Medical Center, Heart Institute in Ohio. “Whether these effects on quality of life can be reduced through the use of psychotherapy needs to be assessed.”
Co-authors are William J. Bonney, M.D.; Amy Cassedy Ph.D.; Douglas Y. Mah, M.D.; Ronn E. Tanel, M.D.; Jason R. Imundo, M.D.; Anoop K. Singh, M.D.; Mitchell I. Cohen, M.D., Christina Y. Miyake, M.D.; Kara Fawley, B.S.; and Bradley S. Marino, M.D.
Author disclosures and sources of funding are on the manuscript.
For the latest heart and stroke news, follow us on twitter: @HeartNews
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding
Additional resources, including multimedia, are available in the right column.
For Media Inquiries: (214) 706-1173
For Public Inquiries: (800) AHA-USA1 (242-8721)